DK2346833T3 - Diazonium-fri fremgangsmåde til fremstilling af et indazolmellemprodukt i syntesen af bicyclisk 5-(trifluormethoxy)-1h-3-indazolcarboxylsyreamider - Google Patents
Diazonium-fri fremgangsmåde til fremstilling af et indazolmellemprodukt i syntesen af bicyclisk 5-(trifluormethoxy)-1h-3-indazolcarboxylsyreamiderInfo
- Publication number
- DK2346833T3 DK2346833T3 DK09783778.5T DK09783778T DK2346833T3 DK 2346833 T3 DK2346833 T3 DK 2346833T3 DK 09783778 T DK09783778 T DK 09783778T DK 2346833 T3 DK2346833 T3 DK 2346833T3
- Authority
- DK
- Denmark
- Prior art keywords
- indazolcarboxyl
- acidamides
- trifluormethoxy
- indazol
- diazonium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10477708P | 2008-10-13 | 2008-10-13 | |
| PCT/EP2009/062952 WO2010043515A1 (en) | 2008-10-13 | 2009-10-06 | Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2346833T3 true DK2346833T3 (da) | 2013-04-29 |
Family
ID=41508367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09783778.5T DK2346833T3 (da) | 2008-10-13 | 2009-10-06 | Diazonium-fri fremgangsmåde til fremstilling af et indazolmellemprodukt i syntesen af bicyclisk 5-(trifluormethoxy)-1h-3-indazolcarboxylsyreamider |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8232412B2 (da) |
| EP (1) | EP2346833B1 (da) |
| JP (1) | JP5425915B2 (da) |
| KR (1) | KR101338726B1 (da) |
| CN (1) | CN102186826B (da) |
| BR (1) | BRPI0920187A2 (da) |
| CA (1) | CA2740311C (da) |
| DK (1) | DK2346833T3 (da) |
| ES (1) | ES2407647T3 (da) |
| IL (1) | IL211931A (da) |
| MX (1) | MX2011003429A (da) |
| PL (1) | PL2346833T3 (da) |
| SI (1) | SI2346833T1 (da) |
| WO (1) | WO2010043515A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2933398B1 (fr) | 2008-07-04 | 2011-02-18 | Saint Gobain Ct Recherches | Grains fondus d'oxydes comprenant al, ti et mg et produits ceramiques comportant de tels grains |
| TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α７活化劑之用途 |
| US20140171448A1 (en) | 2011-01-27 | 2014-06-19 | Novartis Ag | Use of nicotinic acetylcholine receptor alpha 7 activators |
| CA2830458A1 (en) | 2011-03-18 | 2012-09-27 | Novartis Ag | Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease |
| JO3766B1 (ar) | 2011-10-20 | 2021-01-31 | Novartis Ag | منشط مستقبل أسيتيل كولين الفا - 7 النيكوتيني |
| CN102837985A (zh) * | 2012-09-21 | 2012-12-26 | 广州广电运通金融电子股份有限公司 | 金融自助设备及其薄片介质传输系统和传输方法 |
| EP2931315B1 (en) | 2012-12-11 | 2017-11-29 | Novartis AG | Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| BR112015016995B8 (pt) | 2013-01-15 | 2022-07-26 | Novartis Ag | Uso de agonistas do receptor alfa 7 nicotínico de acetilcolina |
| BR112015016992A8 (pt) | 2013-01-15 | 2018-01-23 | Novartis Ag | uso de agonistas do receptor alfa 7 nicotínico de acetilcolina |
| EP2945626B1 (en) | 2013-01-15 | 2018-09-12 | Novartis AG | Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20060391A (en) | 2003-12-22 | 2008-11-28 | Memory Pharmaceuticals Corporation, | Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof |
| MXPA06010852A (es) | 2004-03-25 | 2007-01-16 | Memory Pharm Corp | Indazoles, benzotiazoles, benzoisotiazoles, bencisoxazoles y preparacion y usos de los mismos. |
| WO2006001894A1 (en) | 2004-04-22 | 2006-01-05 | Memory Pharmaceutical Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| DE602005027452D1 (de) | 2004-05-07 | 2011-05-26 | Memory Pharm Corp | 1h-indazole, benzothiazole, 1,2-benzisoxazole, 1,2-benzisothiazole und chromone und deren herstellung und verwendungen |
| DE102004054666A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| US20060142247A1 (en) | 2004-12-17 | 2006-06-29 | Guy Georges | Tricyclic heterocycles |
| PL1828179T3 (pl) | 2004-12-22 | 2010-08-31 | Memory Pharm Corp | Ligandy dla receptorów nikotynowych alfa-7 przeciwko chorobom związanym z OUN |
| CN101312968A (zh) * | 2005-09-23 | 2008-11-26 | 记忆药物公司 | 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途 |
-
2009
- 2009-10-06 DK DK09783778.5T patent/DK2346833T3/da active
- 2009-10-06 MX MX2011003429A patent/MX2011003429A/es active IP Right Grant
- 2009-10-06 PL PL09783778T patent/PL2346833T3/pl unknown
- 2009-10-06 KR KR1020117010544A patent/KR101338726B1/ko not_active IP Right Cessation
- 2009-10-06 BR BRPI0920187A patent/BRPI0920187A2/pt not_active IP Right Cessation
- 2009-10-06 ES ES09783778T patent/ES2407647T3/es active Active
- 2009-10-06 WO PCT/EP2009/062952 patent/WO2010043515A1/en active Application Filing
- 2009-10-06 CA CA2740311A patent/CA2740311C/en active Active
- 2009-10-06 CN CN200980140562.3A patent/CN102186826B/zh not_active Expired - Fee Related
- 2009-10-06 JP JP2011530467A patent/JP5425915B2/ja not_active Expired - Fee Related
- 2009-10-06 SI SI200930588T patent/SI2346833T1/sl unknown
- 2009-10-06 EP EP09783778A patent/EP2346833B1/en not_active Not-in-force
- 2009-10-09 US US12/576,259 patent/US8232412B2/en not_active Expired - Fee Related
-
2011
- 2011-03-24 IL IL211931A patent/IL211931A/en not_active IP Right Cessation
-
2012
- 2012-06-21 US US13/528,894 patent/US8354536B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011003429A (es) | 2011-05-02 |
| SI2346833T1 (sl) | 2013-06-28 |
| KR20110067063A (ko) | 2011-06-20 |
| US20120259120A1 (en) | 2012-10-11 |
| CN102186826A (zh) | 2011-09-14 |
| EP2346833A1 (en) | 2011-07-27 |
| BRPI0920187A2 (pt) | 2019-08-27 |
| CN102186826B (zh) | 2015-06-17 |
| AU2009304171A1 (en) | 2010-04-22 |
| EP2346833B1 (en) | 2013-03-27 |
| JP5425915B2 (ja) | 2014-02-26 |
| US20100094011A1 (en) | 2010-04-15 |
| KR101338726B1 (ko) | 2013-12-06 |
| US8232412B2 (en) | 2012-07-31 |
| JP2012505175A (ja) | 2012-03-01 |
| ES2407647T3 (es) | 2013-06-13 |
| PL2346833T3 (pl) | 2013-08-30 |
| IL211931A (en) | 2016-07-31 |
| US8354536B2 (en) | 2013-01-15 |
| IL211931A0 (en) | 2011-06-30 |
| CA2740311A1 (en) | 2010-04-22 |
| WO2010043515A1 (en) | 2010-04-22 |
| CA2740311C (en) | 2013-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2346833T3 (da) | Diazonium-fri fremgangsmåde til fremstilling af et indazolmellemprodukt i syntesen af bicyclisk 5-(trifluormethoxy)-1h-3-indazolcarboxylsyreamider | |
| DK2280696T3 (da) | Modulatorer af prostacyclin (PG12)-receptoren til anvendelse til behandling af lidelser relateret til denne | |
| DK2310437T3 (da) | Fremgangsmåde til kontinuerlig fremstilling af polyestere | |
| DK2155838T3 (da) | Fremgangsmåde til fremstilling af forgrenede carbonhydrider | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
| DK2046767T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
| DK2269063T3 (da) | Forudsigelse af risiko for større uønskede hjertehændelser | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK3289876T3 (da) | Forbindelser til behandling af cancer | |
| DK2247577T4 (da) | Fremgangsmåde til regioselektiv syntese af 1-alkyl-3-haloalkyl-pyrazol-4-carboxylsyrederivater | |
| DK2231565T3 (da) | Fremgangsmåder til fremstilling af clorerede carbonhydrider | |
| DK2356093T3 (da) | Carbazolforbindelser og terapeutiske anvendelser af forbindelserne | |
| DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
| DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
| BRPI0923433A2 (pt) | Síntese de compostos fucosilados | |
| DK2152290T3 (da) | Fremgangsmåder til indgivelse af anti-il-5-antistoffer | |
| DK2300443T3 (da) | Triazolderivater, der er anvendelige til behandling af sygdomme | |
| DK2114853T3 (da) | Fremgangsmåde til fremstilling af glycerolestere | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| DK2121553T3 (da) | Fremgangsmåde til fremstillingen af terapeutisk værdi-fulde triphenylbutenderivater | |
| DK2146944T3 (da) | Fremgangsmåde til fremstillingen af 18f-mærkede folater | |
| DK2382232T3 (da) | Fremgangsmåde til fremstilling af bivalirudin | |
| DK2081675T3 (da) | Syntese af biodiesel | |
| DK2462098T3 (da) | Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre |